Enhancing Patient-Centered Health Technology Assessment: A Modified Delphi Panel for PICOS Scoping in Spinal Muscular Atrophy [0.03%]
改良式德尔菲专家咨询法在脊髓性肌萎缩症患者导向型卫生技术评估PICOS范围界定中的应用
Emanuele Arcà,Adele Barlassina,Adaeze Eze et al.
Emanuele Arcà et al.
Highlights: What is the main finding? This paper illustrates how systematic PICOS scoping can be operationalized within JCAs through Delphi consensus methods for mapping and reconciling multiple national and patient persp...
Knowledge Spillover and Innovation in Healthcare: A Comparative Study of Social Media Interaction Between Medical Technology Companies and Healthcare Professionals in Austria [0.03%]
奥地利医疗技术公司与医务人员的社交媒体互动对医疗卫生知识溢出和创新的影响比较研究
Mariella Zilahi-Lugbauer,Harald Stummer
Mariella Zilahi-Lugbauer
Background : Interactions between healthcare professionals and medical technology companies on social media are central to understanding how variations in knowledge spillover and innovation performance vary. Aim : This study investigates ho...
Overcoming Patient Access Barriers in Complex Conditions: Lessons from Schizophrenia for Broader Healthcare Applications [0.03%]
精神分裂症的患者访问障碍及对更广泛医疗保健应用的经验教训
Saartje Burgmans,Anne Rieper Hald,Sayagi Tina Markandaier et al.
Saartje Burgmans et al.
Patient access to innovative care for complex conditions like schizophrenia remains limited by systemic, clinical and policy-level barriers. Cognitive impairment associated with schizophrenia (CIAS) illustrates how critical symptom domains ...
European Joint Clinical Assessment PICO Scoping Process: Analysis of Current Approaches and Recommendations [0.03%]
欧洲联合临床评估PICO范围界定过程：当前方法分析及建议
Kalpana D&#x;Oca,Eline Darquennes,Chloé Garrigues et al.
Kalpana D&#x;Oca et al.
The PICO framework determines the scope of the Joint Clinical Assessment (JCA) under the EU HTA Regulation (EU HTAR), with PICO consolidation being a critical final step of the scoping process. Due to limited clarity on how consolidation wo...
Conformity Assessment of Medical Devices: An Overview from a Notified Body [0.03%]
医疗器械符合性评定概述——来自公告机构的观点
Andreas F Stange,Elaine Julian
Andreas F Stange
This perspective provides an in-depth analysis of the role and tasks of Notified Bodies (NBs) under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). It explores the conformity assessment process and highlights ...
Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy [0.03%]
欧洲卫生技术评估绩效测量框架的开发：欧洲准入学院采用德尔菲方法确定以利益相关者为中心的关键绩效指标
Elaine Julian,Nicolas S H Xander,Konstantina Boumaki et al.
Elaine Julian et al.
Background: The objective of this work was to support the implementation of the European Health Technology Assessment Regulation (EU HTAR) and optimize performance of the evolving EU HTA system. Therefore, an inclusive mu...
The Pharmaceutical Innovativeness Index: Supporting Value-Based Economic Regulation of Innovative Medicines [0.03%]
药品创新指数——支持创新型药物基于价值的经济监管
Ludmila Peres Gargano,Marcus Carvalho Borin,Wallace Mateus Prata et al.
Ludmila Peres Gargano et al.
The regulation of new medicine prices must balance financial sustainability with equitable access to innovation. Value-Based Pricing (VBP) strategies seek to align drug prices with their clinical and societal impact. The Pharmaceutical Inno...
Cost-Effectiveness of Electrical Stimulation Therapy in the Treatment of Chronic Wounds: A Systematic Review, Meta-Analysis and Economic Analysis [0.03%]
电刺激治疗慢性难愈伤口的成本效益系统综述、荟萃分析及经济性分析
Jennifer M Smith,John Posnett,Emma J Woodmansey
Jennifer M Smith
Hard-to-heal wounds are a major burden to healthcare systems. Electrical stimulation therapy (EST) is known to improve clinical outcomes, but cost-effectiveness analysis is lacking. The aim was to explore the cost-effectiveness of EST with ...
François Houÿez,Julien Delaye
François Houÿez
In the process of determining whether a health technology should be covered by healthcare systems, patients and their representatives were initially excluded from both evaluations and decision-making. In Europe, direct dialogue between pati...
Patient Perspectives on Health Insurance Design: A Mixed-Methods Analysis [0.03%]
患者对健康保险设计的看法：混合方法分析
Bridget Doherty,Kimberly Hooks,Ulrich Neumann et al.
Bridget Doherty et al.
There remains a persistent lack of patient-centered evidence on insurance reform and real-world experiences of patients with chronic disease. This study gathered insights around insurance design from chronic disease beneficiaries. This mixe...